Terumo Will Top Blood Transfusion Device Space With $2.6 Billion Acquisition
This article was originally published in The Gray Sheet
Executive Summary
Diversified Japanese device maker Terumo will become the global leader in the blood transfusion product market with its planned $2.6 billion acquisition of privately owned CaridianBCT.
You may also be interested in...
Medical Device and In Vitro Diagnostics/Research Deals Statistics Quarterly, Q1 2011
For the first three months of 2011, medical device companies raised $733 million, with venture rounds bringing in $494 million. Two-thirds of the $3.9 billion in M&A activity came from Terumo's monstrous $2.6 billion cash takeover of US blood processing equipment maker CaridianBCT Holding. Buoyed by Opko Health's $105 million follow-on, the FOPO category represented almost half of the first quarter's in vitro diagnostics/research $370 million total. The stand-out IVD acquisition was Danaher's $6.8 billion takeover of publicly traded Beckman Coulter.
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.